MIDAS · 2 minutes
Migraine disability (MIDAS)
Five questions counting days lost or impaired by headache in the last 3 months — work, household, social. Result categorises disability from minimal to severe and shapes the treatment plan.
Over the last 3 months, how many days of work or school did you miss because of your headaches?
Educational tool — not a diagnosis. MIDAS, Stewart, Lipton et al. 1999. Used in headache specialty clinics globally to grade migraine-related disability.
Frequently asked
Plain-language answers about migraine disability, this screener, and what evaluation costs at a Class A hospital in China.
- When should I consider migraine prophylaxis?
- International guidelines recommend prophylaxis at MIDAS Grade III (≥11 days disability/3 months) or with ≥4 headache days/month. CGRP monoclonal antibodies (erenumab, fremanezumab) and oral preventives (topiramate, candesartan) are well-supported.
- What's the cost of CGRP migraine prevention in China?
- Erenumab (Aimovig) at Class A neurology departments is approximately $200–280/month vs $700/month US private pay. Generic oral preventives (topiramate, propranolol) are $5–25/month.
- When should I see a neurologist for headaches?
- Sudden severe headache, neurologic symptoms (visual loss, weakness, confusion), age > 50 with new headaches, or headaches not responding to standard care all warrant neurology evaluation.
About this screener
MIDAS, Stewart, Lipton et al. 1999. Used in headache specialty clinics globally to grade migraine-related disability.
What this screener covers
- Migraine without aura(ICD-10 G43.0)
- Chronic migraine(ICD-10 G43.7)
Validated source
Medical review
Reviewed by Panda Touring Care medical team (Neurology coordinator review) · last reviewed 2025-04-01
Other self-assessments
Weight loss & GLP-1 candidacy screener
BMI, waist circumference, prior attempts and comorbidities — see whether GLP-1 medication, lifestyle support, or surgical evaluation is the best next step.
Psychiatry · NeurodevelopmentalAdult ADHD self-screener (ASRS-v1.1)
The 6-item Part A of the WHO Adult ADHD Self-Report Scale. Validated screen for adults 18+. Not a diagnosis — but a strong indicator of whether a full evaluation is warranted.
Psychiatry · Mental healthDepression screener (PHQ-9)
The 9-item Patient Health Questionnaire — the most widely used validated depression screener in primary care worldwide. Free, 3 minutes, immediate results.
Psychiatry · Mental healthAnxiety screener (GAD-7)
The 7-item Generalised Anxiety Disorder scale — the standard validated screener for adult anxiety. Free, 2 minutes.
Hepatology · Addiction medicineAlcohol use screener (AUDIT-C)
Three-question alcohol use screener used by the WHO and US Veterans Affairs. Identifies hazardous drinking patterns in under a minute.
Sleep medicineInsomnia severity index (ISI)
Validated 7-item insomnia severity scale. Identifies clinically significant insomnia and tracks treatment response.